〈事業紹介〉
PLGAナノ粒子によるDDS技術を応用した商品の研究開発及び製造事業
2021 年 64 巻 p. 81-83
詳細
2021 年 64 巻 p. 81-83
Material Business Division possesses advanced PLGA (Poly-Lactic-co-Glycolic Acid) nanoparticle technologies having DDS (Drug Delivery System) characteristics. The PLGA nanoparticles proposed and provided by us have already been applied to not only drug formulation but also cosmetics, quasi-drugs, medical devices such as stent and balloon catheters. In 2004, we launched to sell both a functional skincare cosmetic brand “NanoCrysphere®” and a haircare brand “NanoImpact®” with the PLGA nanoparticles. Currently, we are also promoting ODM productions and sales for various types of unique cosmetics such as powdery serum and eyelash serum, etc., utilizing our PLGA nanoparticle technologies.
